Watchlist Price Alert

Rapport Therapeutics Inc.... (RAPP)

NASDAQ: RAPP · Real-Time Price · USD

10.83

-0.12 (-1.10%)

At close: Jun 18, 2025, 2:55 PM

Rapport Therapeutics Common Stock Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	208K	152K	76K	n/a	21K	15K
Gross Profit	n/a	n/a	n/a	-208K	-152K	-76K	n/a	-21K	-15K
Operating Income	-27.11M	-23.52M	-21.64M	-20.8M	-17.09M	-14.79M	-9.56M	-6.63M	-5.19M
Interest Income	3.04M	3.54M	4.1M	2.68M	1.81M	1.38M	856K	221K	75K
Pretax Income	-24.06M	-19.98M	-17.54M	-18.12M	-22.67M	-13.51M	-8.71M	-6.41M	-6.15M
Net Income	-24.06M	-19.98M	-17.54M	-18.12M	-22.67M	-13.52M	-8.71M	-6.41M	-6.15M
Selling & General & Admin	7.54M	6.32M	6.1M	4.9M	4.44M	2.92M	1.98M	1.89M	1.28M
Research & Development	19.57M	17.2M	15.54M	15.69M	12.5M	11.8M	7.58M	4.72M	3.9M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	27.11M	23.52M	21.64M	20.59M	16.94M	14.72M	9.56M	6.61M	5.18M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	-208K	-152K	-76K	n/a	-21K	-15K
Cost & Expenses	n/a	23.52M	21.64M	20.8M	17.09M	14.79M	9.56M	6.63M	5.19M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	6K	1K	2K	1K
Shares Outstanding (Basic)	352.67M	192.88M	191.71M	201.17M	194.57M	180.79M	190.98M	201.17M	194.57M
Shares Outstanding (Diluted)	352.67M	192.88M	191.71M	201.17M	194.57M	180.79M	190.98M	201.17M	194.57M
EPS (Basic)	-0.68	-0.1	-0.09	-0.09	-0.12	-0.07	-0.05	-0.03	-0.03
EPS (Diluted)	-0.68	-0.1	-0.09	-0.09	-0.12	-0.07	-0.05	-0.03	-0.03
EBITDA	-27.11M	-23.26M	-21.42M	-20.8M	-16.94M	-13.34M	-9.54M	-6.61M	-5.18M
EBIT	n/a	-23.52M	-21.64M	-20.8M	-17.09M	-13.39M	-9.56M	-6.63M	-5.19M
Depreciation & Amortization	n/a	260K	219K	208K	152K	53K	23K	21K	15K